Matinas BioPharma (NYSE AMER: MTNB) is a biopharmaceutical company focused on improving the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology. The Company is developing its own internal portfolio of products as well as partnering with leading pharmaceutical companies to develop novel formulations that capitalize on the unique characteristics of the LNC platform. Preclinical and clinical data have demonstrated that this novel technology can provide solutions to many of the challenges in achieving safe and effective intracellular delivery, for both small molecules and larger, more complex molecules, such as mRNA, DNA plasmids, antisense oligonucleotides, and vaccines. The combination of a unique mechanism of action and flexibility with formulation and route of administration (including oral), positions Matinas’ LNC technology to potentially become the preferred next-generation intracellular drug delivery vehicle with distinct advantages over both lipid nanoparticles and viral vectors.
View Top Employees from Matinas BioPharmaWebsite | http://www.matinasbiopharma.com/ |
Ticker | MTNB |
Revenue | $120000 |
Employees | 33 (32 on RocketReach) |
Founded | 2011 |
Address | 1545 Route 206 Suite 302, Bedminster, New Jersey 07921, US |
Phone | (908) 443-1860 |
Technologies |
JavaScript,
HTML,
Twitter
+17 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Biopharma, Pharmaceuticals, Biotechnology, Healthcare, Health Care, Science and Engineering, Therapeutics |
Web Rank | 10 Million |
Keywords | Matinas Biopharma, Mat9001, Mtnb Stock, Mtnb, Mat9001 Phase 3 |
Competitors | Alzheon, Inc. | Preserving Future Memories, Entera Bio Ltd., Otonomy, Inc, QCONF Conferencing, Soligenix, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Matinas BioPharma employee's phone or email?
The Matinas BioPharma annual revenue was $120000 in 2024.
Jerry Jabbour is the CEO of Matinas BioPharma.
32 people are employed at Matinas BioPharma.
Matinas BioPharma is based in Bedminster, New Jersey.
The NAICS codes for Matinas BioPharma are [32, 32541, 325, 3254].
The SIC codes for Matinas BioPharma are [283, 28].